Baxter International | BAX - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Abbott USD 4.24B 117M 2025-12
AngioDynamics USD 35.39M 3.51M 2025-09
Artivion USD 18.34M 2.3M 2026-03
AtriCure USD 70.06M 8.34M 2026-03
Avanos Medical USD 52.3M 3.2M 2026-03
Baxter International USD 1.09B 87M 2026-03
Becton, Dickinson and Co. USD 5.93B 204M 2026-03
Boston Scientific USD 1.14B 3M 2026-03
Cooper Companies USD 233.3M 7.5M 2026-03
Dexcom USD 1.94B 109.1M 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Fresenius EUR 1.65B 564M 2025-12
Globus Medical USD 103.66M 4.81M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
ICU Medical USD 173.98M 19.61M 2026-03
Inogen USD 21.22M 684K 2025-09
Insulet USD 149.8M 74.8M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
Intuitive Surgical USD 1.85B 68.6M 2026-03
J&J USD 10.46B 1.53B 2026-03
Laboratory Of America USD 695.7M 145.1M 2026-03
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 67.85M 7.3M 2026-03
Quest Diagnostics USD 1.5B 100M 2026-03
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.8B 301M 2025-12
Tandem Diabetes Care USD 59.86M 12.79M 2026-03
Teleflex USD 143.63M 13.43M 2026-03
Terumo JPY 89.76B 7.73B 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03